- Home
- IMMP vs NEN Comparison
IMMP vs NEN Comparison
Compare IMMP & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NEN
- Stock Information
- Founded
- IMMP 1987
- NEN 1977
- Country
- IMMP Australia
- NEN United States
- Employees
- IMMP N/A
- NEN N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- IMMP Health Care
- NEN Real Estate
- Exchange
- IMMP Nasdaq
- NEN Nasdaq
- Market Cap
- IMMP 221.2M
- NEN 262.4M
- IPO Year
- IMMP N/A
- NEN N/A
- Fundamental
- Price
- IMMP $1.72
- NEN $73.75
- Analyst Decision
- IMMP Buy
- NEN
- Analyst Count
- IMMP 1
- NEN 0
- Target Price
- IMMP $7.00
- NEN N/A
- AVG Volume (30 Days)
- IMMP 98.8K
- NEN 822.0
- Earning Date
- IMMP 02-27-2025
- NEN 01-01-0001
- Dividend Yield
- IMMP N/A
- NEN 6.55%
- EPS Growth
- IMMP N/A
- NEN 58.97
- EPS
- IMMP N/A
- NEN 4.56
- Revenue
- IMMP $3,019,249.00
- NEN $82,531,485.00
- Revenue This Year
- IMMP $50.37
- NEN N/A
- Revenue Next Year
- IMMP N/A
- NEN N/A
- P/E Ratio
- IMMP N/A
- NEN $16.05
- Revenue Growth
- IMMP 24.11
- NEN 6.12
- 52 Week Low
- IMMP $1.32
- NEN $67.50
- 52 Week High
- IMMP $2.72
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- IMMP 50.07
- NEN 39.49
- Support Level
- IMMP $1.53
- NEN $73.00
- Resistance Level
- IMMP $1.71
- NEN $73.25
- Average True Range (ATR)
- IMMP 0.07
- NEN 0.22
- MACD
- IMMP 0.01
- NEN 0.03
- Stochastic Oscillator
- IMMP 72.41
- NEN 16.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.